NCT03887988

Brief Summary

Approximately 300 patients presenting orbital blow-out fracture will be enrolled prospectively in this registry. All patients, surgically and nonsurgically treated as per standard (routine) of care will be followed-up (FU) within the registry for a period of 6 months.

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Longer than P75 for all trials

Geographic Reach
11 countries

13 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 25, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

6.3 years

First QC Date

March 18, 2019

Last Update Submit

December 15, 2025

Conditions

Keywords

Fracture fixationOrbital implantMidface fractureDiplopia

Outcome Measures

Primary Outcomes (1)

  • Diplopia

    The degree of diplopia is quantified by measuring the field of single binocular vision, ranging from 0 to 3. 0: no diplopia 1. mild (diplopia appears more than 30 degrees from the primary position) 2. moderate (diplopia appears between 10 and 30 degrees from the primary position) 3. severe (diplopia appears within 10 degrees from the primary position)

    24 weeks post-treatment

Secondary Outcomes (4)

  • Globe position

    6, 12, 24 weeks post-treatment

  • Visual acuity

    6, 12, 24 weeks post-treatment

  • Extra-ocular mobility

    6, 12, 24 weeks post-treatment

  • Patient-reported outcomes

    pre-treatment, 6, 12, 24 weeks post-treatment

Study Arms (1)

Orbital Fracture

Patients with dislocated fracture of the inferior and/or medial orbital wall

Procedure: Primary "early" reconstructionOther: NonsurgicalProcedure: Primary "delayed" reconstructionProcedure: Secondary reconstruction

Interventions

Second surgical reconstruction of the fracture after a primary reconstruction.

Also known as: Secondary surgery
Orbital Fracture

Primary surgical reconstruction of the fracture within 3 weeks after injury

Also known as: Operative, Surgical
Orbital Fracture

Nonsurgical treatment of fracture

Also known as: Conservative
Orbital Fracture

Primary surgical reconstruction of the fracture more than 3 weeks after injury

Also known as: Operative, Surgical
Orbital Fracture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients older than 18 years old with displaced fracture of the inferior and/or medial orbital wall (blow-out fractures) that require treatment (either surgically or non-surgically)

You may qualify if:

  • Age 18 years or older at the time of the injury
  • Patients with a dislocated fracture of the inferior and/or medial orbital wall, either
  • Diagnosed at the study site via CT or CBCT within 2 weeks of the date of the injury, OR
  • Who will undergo secondary reconstruction

You may not qualify if:

  • Bilateral orbital fracture
  • Concomitant displaced fracture(s) of the orbital roof or any other area of the orbit
  • Concomitant ruptured globe
  • Displaced fracture of the malar bone
  • Displaced midface fracture
  • Displaced nasoorbitoethmoidal (NOE) fracture or complex zygoma fractures
  • Presence at the time of enrollment of any disease with influence on eye motility (eg, strabismus, myasthenia gravis, Graves' ophthalmopathy)
  • Previous radiotherapy in the orbital region
  • Participation in any other medical device or medicinal product study within the previous month(s) that could influence the results of the present study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

UC Davis

Sacramento, California, 95817, United States

Location

Medical Center Hamburg Eppendorf

Hamburg, Germany

Location

Klinikum der LMU München

Munich, 80337, Germany

Location

Eramus MC

Rotterdam, Netherlands

Location

Mayo Hospital

Lahore, Pakistan

Location

Hamad Medical Corporation

Doha, Qatar

Location

Emergency Clinical County Hospital of Constanta

Constanța, Romania

Location

Federal State Budgetary Institution "National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Healthcare of the Russian Federation

Moscow, Russia

Location

Clinic for Maxillofacial Surgery, University of Belgrade

Belgrade, Serbia

Location

King Edward VIII Hospital

Durban, South Africa

Location

Hospital Vall d' Hebron

Barcelona, Catalonia, Spain

Location

12 de Octubre University Hospital

Madrid, Madrid, Spain

Location

Uppsala University Hospital

Uppsala, Sweden

Location

Universitaetsspital Basel

Basel, Switzerland

Location

Related Publications (1)

  • Strabbing EM; OFx Registry Study Group; Wolvius EB. Surgical versus non-surgical management of orbital fractures: study protocol for evidence generation of a prospective multicentre observational cohort registry. BMJ Open. 2025 Jul 30;15(7):e100508. doi: 10.1136/bmjopen-2025-100508.

MeSH Terms

Conditions

Orbital FracturesDiplopia

Interventions

Surgical Procedures, OperativePeriodontal DebridementConservative Treatment

Condition Hierarchy (Ancestors)

Maxillofacial InjuriesFacial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesSkull FracturesFractures, BoneWounds and InjuriesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dental ProphylaxisPeriodonticsDentistryTherapeutics

Study Officials

  • Eppo B. Wolvius, Prof.

    Department of Oral & Maxillofacial Surgery, Erasmus MC, Rotterdam

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2019

First Posted

March 25, 2019

Study Start

November 1, 2019

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

December 19, 2025

Record last verified: 2025-12

Locations